When people are clamoring for vaccines in India and in Brazil, it just makes us look like a nation of sulky adolescents. … So if it s absolutely necessary, sure, although it s tough to swallow, said Hotez, who is the dean for the National School of Tropical Medicine at the Baylor College of Medicine.
The pace of vaccinations has been slipping nationwide. The U.S. is averaging about 2.3 million shots per day, which is down 32% from the peak last month, according to the Centers for Disease Control and Prevention.
The federal government is changing vaccine allocation strategies across the country amid the slowing pace of vaccinations. States can turn down doses that they don t need and the shots will be redistributed to areas with higher demand.
When people are clamoring for vaccines in India and in Brazil, it just makes us look like a nation of sulky adolescents. … So if it s absolutely necessary, sure, although it s tough to swallow, said Hotez, who is the dean for the National School of Tropical Medicine at the Baylor College of Medicine.
The pace of vaccinations has been slipping nationwide. The U.S. is averaging about 2.3 million shots per day, which is down 32% from the peak last month, according to the Centers for Disease Control and Prevention.
The federal government is changing vaccine allocation strategies across the country amid the slowing pace of vaccinations. States can turn down doses that they don t need and the shots will be redistributed to areas with higher demand.
Heather SImpson is vaccinated against COVID-19 at Baylor University Medical Center in Dallas.
Tara Haelle
Heather Simpson dressed up as measles for Halloween in 2019 because it was, as she told her growing following on social media, the “least scary thing I could think of.” The Dallas mom was then a full-fledged anti-vaccine influencer, drawing tens of thousands of likes and comments on her Facebook posts that denied the safety and necessity of childhood vaccinations.
But today most of the thousands who recirculated those posts have abandoned and shunned her. On a mid-April afternoon, Simpson battled traffic into downtown Dallas to reach Baylor University Medical Center for her first dose of the Pfizer-BioNTech vaccine against COVID-19. Clad in jeans and a black “Kiss Me I’m Vaccinated” T-shirt and a mask the upbeat thirty-year-old said she wouldn’t back out, despite her anxiety.
Image used for representational purpose only
HYDERABAD: Vaccine maker Biological E Ltd has received approval from the subject expert committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to start phase III clinical trials of its Covid-19 subunit vaccine candidate. The company is developing the vaccine with Texas-based Baylor College of Medicine (BCM).
The phase III trials of the recombinant protein vaccine will be conducted on 1,268 healthy volunteers in the 18 to 80 age bracket across 15 sites in India to evaluate the immunogenicity and safety of the vaccine. This is part of a larger global phase III study, Biological E said on Saturday.